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Roles of E2F1 in mesangial cell proliferation in vitro. advances in the cell cycle regulation have been accompa-
Background. The proliferation of mesangial cells is a com- nied by advances in our understanding of the mecha-
mon feature of many glomerular diseases. E2F transcription nisms that regulate mesangial cell proliferation. Certainfactors play an important role in the regulation of the cell cycle.
pathogenic mitogens increase the expression of G1However, the regulation of the mesangial cell cycle and the
cyclins, cyclin D1, cyclin E, and cyclin A, in mesangialparticipation of the E2F family (E2F1 through E2F5) in mesan-
gial cells have not been clarified. Therefore, we investigated cells in vitro [5–9]. Shankland et al have also demon-
the roles of the E2F family in the mesangial cell cycle. strated an increased cyclin D1 and cyclin A expression
Methods. To elucidate the importance of the E2F family, in experimental glomerulonephritis in vivo [10].we investigated the mesangial cell cycle by examining the cell
The conjunction of these G1 cyclins with cyclin-depen-count and thymidine incorporation, and compared it with the
dent protein kinases (CDKs) facilitates phosphorylationprotein expression of E2F. Using adenovirus-mediated gene
transfer, the cell cycle and apoptosis were examined by mea- of retinoblastoma protein (pRb) families with the release
surement of thymidine incorporation, flow cytometry, and cas- of the E2F family [11, 12]. The E2F family is identified
pase 3 activity. We also studied the interaction between E2F1 as five closely related proteins (E2F1 through E2F5)
and G1 cyclins by promoter assay, Western blotting, and CDK
[13–16]. The E2F transcription factor regulates cell cyclekinase assay.
progression by influencing the expression of proteinsResults. E2F1 increased 20-fold in G1/S phase transition.
E2F1 overexpression facilitated the mesangial cell cycle and required for the G1/S phase transition and DNA synthe-
later induced apoptosis. Furthermore, E2F1 overexpression sis [17]. Although the E2F family is considered critical
increased the promoter activities and protein expressions of for the passage of cells through the G1 and into the S
G1 cyclins, cyclin D1, cyclin E, cyclin A. The up-regulation of
phase [18, 19], the role of the E2F family in the mesangialG1 cyclins contributed to the activation of CDK4 and CDK2.
cell cycle has not been clearly elucidated. Several recentConclusions. In mesangial cells, we conclude that E2F1
plays an important role in G1/S phase transition and in apopto- studies have showed that E2F decoy oligonucleotides
sis. E2F1 regulates the mesangial cell cycle through two distinct could suppress mesangial cell proliferation in vitro [20]
pathways. First, E2F1 directly transcribes genes that are neces- and in vivo [21]. These findings suggest that suppression
sary for DNA synthesis, and second, it promotes cell cycle
of E2F transcriptional activity could lead to a novel ther-progression via the induction of G1 cyclins.
apeutic approach. However, the role of the E2F family
has not been directly shown in mesangial cells. E2F and
G1 cyclins are known to form a complex network and toMesangial cell proliferation is an important feature of
cooperate in promoting cell cycle progression, but thesemesangial proliferative glomerulonephritis, which pro-
interactions have not been examined in mesangial cells.gresses to end-stage renal disease [1, 2]. Although a vari-
G1 cyclins and E2F itself have E2F binding sites withinety of therapies have been used to retard the progression
their promoter regions [22–26]. Free E2F, which bindsof renal impairment, no curative treatment has yet been
to these promoter regions, increases the expression ofdevised to suppress mesangial cell proliferation [3, 4].
E2F [23], cyclin E [24], and cyclin A [26], and regulatesTo design a rational therapy, we must first elucidate the
positive and negative feedback loops in certain cell lines.regulation of mesangial cell proliferation. The recent
The mesangial cells are characterized by a fully differen-
tiated morphology and rarely proliferate in adult animals
[27]. The expressions of cyclin D1, cyclin E, and cyclinKey words: glomerulonephritis, cell cycle, G1/S cell phase, transcrip-
tion factor, apoptosis. A are rarely detected in normal quiescent glomerulus
[28]. Investigation of the interactions between cyclinsReceived for publication November 17, 1998
and E2F will broaden our understanding of mesangialand in revised form July 13, 1999
Accepted for publication August 3, 1999 cell cycle control and help us to decide therapeutic means
to suppress mesangial cell proliferation. 1999 by the International Society of Nephrology
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In this study, we showed E2F function directly by using of supernatant to measure the absorbance of a 450 nm
wavelength.adenovirus-mediated overexpression in primary cultured
cells, to our knowledge, for the first time. E2F1 overex-
[3H]-thymidine incorporationpression promoted mesangial proliferation and increased
the expressions of cyclins D1, E, and A. Our data suggest Mesangial cells were plated in 24-well plates. After
that E2F1 plays a central role in the mesangial cell cycle. growing to 80% confluence, they were incubated in
starved medium for 48 hours and were transfected with
AdE2F1 for 24 hours in starved medium. For the last four
METHODS hours, the cells were pulsed with 1 mCi [3H]-thymidine
Adenoviruses (Amersham Pharmacia Biotech, Arlington Heights, IL,
USA). After washing the cells three times in ice-coldReplication-defective, recombinant adenovirus ex-
phosphate-buffered saline (PBS), they were precipitatedpressing E2F1 (AdE2F1), driven by the cytomegalovirus
two times with 10% trichloroacetic acid (TCA), redis-(CMV) immediate-early promoter, was kindly provided
solved in 0.5 m NaOH with 0.1% Triton X-100, andby Dr. J.R. Nevins [29]. A recombinant adenovirus ex-
counted in Aquasol-2 scintillation cocktail (NEN Re-pressing the LacZ gene (AxCALacZ) was kindly pro-
search Products, Boston, MA, USA).vided by Dr. I. Saito [30]. Each adenovirus was propa-
gated, purified, and titrated by plaque assay on 293 cells.
Preparation of nuclear protein from mesangial cellsViral stocks were stored at 2808C and thawed on ice
and Western blot analysisfor five minutes before use.
The cells harvested with trypsin were washed in PBS.
Mesangial cell culture and adenovirus infection in vitro After centrifugation at 1000 r.p.m. for five minutes at
48C, the pellets were resuspended in buffer containingMesangial cell strains from male Sprague-Dawley rats
10 mm HEPES, pH 7.9, 10 mm KCl, 0.1 mm ethylene-were isolated and characterized as previously reported
diaminetetraacetic acid (EDTA), 0.1 mm egtazic acid[31]. Cells were maintained in RPMI1640 medium sup-
(EGTA), 1 mm dithiothreitol (DTT), and 0.5 mm phenyl-plemented with 20% fetal bovine serum, 100 units/ml
methylsulfonyl fluoride (PMSF). Next, after incubationpenicillin, 100 mg/ml streptomycin, 5 mg/ml insulin, 5
for 15 minutes at 48C, 25 ml of 10% Nonidet P-40 wasmg/ml transferrin, 5 ng/ml selenite, 10 mm nonessential
added, and the extract was centrifuged at 12,000 r.p.m.amino acids, and 10 mm sodium pyruvate at 378C in a
for 30 seconds at 48C. The nuclei were extracted with5% CO2 incubator. We used starved medium containing
homogenization buffer containing 20 mm HEPES, pH100 units/ml penicillin, 100 mg/ml streptomycin, 5 mg/ml
7.9, 0.4 m NaCl, 1 mm EDTA, 1 mm EGTA, 1 mm DTT,insulin, 5 mg/ml transferrin, 5 ng/ml selenite, 10 mm
1 mm PMSF, 1 mg/ml aprotinin, and 1 mg/ml pepstatin,nonessential amino acids, and 10 mm sodium pyruvate
and incubated for 15 minutes on a shaking platform atin RPMI 1640 medium to make the cells quiescent. The
48C. After centrifugation of the nuclear extract at 10,000cells used in experiments were from passages 5 to 20.
r.p.m. for 10 minutes at 48C, the supernatant fractionThe cells were subcultured in 10 cm dishes or 24-well
was stored in aliquots at 2808C. Protein concentrationsdishes at a density of 5 3 104 cells/ml, were incubated
were determined by the Bradford method using bovinein medium plus 20% fetal calf serum (FCS) until approxi-
serum albumin (BSA) as a standard. The same amount ofmately 80% confluence, and were then incubated in
nuclear protein was resolved in sodium dodecyl sulfate-starved medium for 48 hours to make the cells quiescent.
polyacrylamide gel electrophoresis (SDS-PAGE). TheWhen using the adenovirus, the medium was removed,
proteins were then transferred to an Immobilon P mem-and the viral solution was added to the culture dishes
brane (Daiichikagaku, Tokyo, Japan). To detect E2F1,for one hour with shaking every 15 minutes. Subse-
E2F2, E2F3, E2F4, cyclin D1, cyclin E, and cyclin A (allquently, the cells were incubated in starved medium for
antibodies purchased from Santa Cruz Biotechnologythe indicated times.
Inc., Santa Cruz, CA, USA), the membrane was incu-
Survival cell count bated with antibody at a dilution of 1:1000 to 1:3000 in
Tris-buffered saline (TBS) containing 0.1% Tween 20To count the number of living cells, we used the Cell
and 5% skim milk for three hours at room temperature.Counting Kit-8 (Wakojyunyaku, Osaka, Japan). The
After the membrane was washed in TBS containing 0.1%mesangial cells were subcultured in 24-well dishes and
incubated in starved medium for 48 hours. The cells were Tween 20, it was incubated with a second antibody in
TBS containing 0.1% Tween 20 and 5% skim milk forstimulated with 20% FCS or infected with adenoviruses
in 400 ml medium. After the indicated hours, 40 ml WST-8 one hour at room temperature. The membrane was visu-
alized using the ECL chemiluminescence system (Amer-(tetrazolium monosodium salt) was added and incubated
for two hours at 378C CO2 incubator. We used 100 ml sham Pharmacia Biotech).
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Northern blot analysis Transient transfections and luciferase assays
Transfection assays were performed in rat mesangialTotal RNA was extracted from the mesangial cells
using TRIREAGENTe (Life Technologies, Gaithers- cells by electroporation methods. Mesangial cells were
grown in 20% FCS containing medium until 80% con-burg, MD, USA). Twenty micrograms of each total RNA
sample were separated on 1% agarose-formaldehyde- fluence and were then incubated in starved medium for
48 hours to stop the cell cycle. After stimulating the cellsmorpholino propanesulfonic acid (MOPS) gel and trans-
ferred to Hybond-N hybridization membrane (Amers- with FCS-containing medium for 24 hours, they were
washed by PBS, collected by trypsinization, and centri-ham Pharmacia Biotech). Northern hybridizations were
carried out at room temperature for 16 hours in a solu- fuged and washed twice by PBS. The cells were put in
0.4 cm cuvettes with 5 mg luciferase reporter plasmidtion containing 5 3 Denhalt’s solution, 2 3 standard
saline citrate (SSC), 0.1% SDS, 100 mg/ml denatured sal- and 5 mg b-galactociderse reporter plasmid, and then
they were transfected by electroporation at 300 V usingmon sperm DNA, and 10% dextran sulfate. Full-length
1.5 kb human E2F1 cDNAs were labeled by the random a Bio-Rad gene pulser (Bio-Rad, Hercules, CA, USA).
Luciferase reporter plasmids driven by the human cyclinpriming method and used as probes for Northern hybrid-
ization. Following hybridization, the membranes were D1 promoter were provided by Dr. M. Eilers. The human
cyclin E promoter was provided by Dr. K. Ohtani, andwashed twice for five minutes at room temperature in 5 3
SSPE and 0.5% SDS, twice at 378C for 15 minutes in the human cyclin A promoter was provided by Dr. J.
Sobczak-Thepot. The cells were incubated in FCS-con-1 3 SSPE and 0.5% SDS, and once at 378C for 15 minutes
in 0.1 3 SSPE and 0.5% SDS and were then exposed to taining medium for 24 hours and infected by adenovirus.
Luciferase activity was measured as described previouslyFuji x-ray film (Fuji Photo Film, Kanagawa, Japan) for
24 to 48 hours at room temperature. The films were 12 hours after infection.
analyzed by BASe (Fuji Photo).
CDK4 and CDK2 kinase assay
Cell cycle analysis by fluorescence-activated cell The immune complex kinase assay was performed using
sorter (FACS) essentially the same methods described by Matsushime
et al [32]. The mesangial cells were incubated with serum-Mesangial cells were cultured in 10 cm dishes. The
cells were incubated in starved medium for 48 hours starved medium for 48 hours. The cells were infected
with 109 pfu/ml AdE2F1 or were stimulated by 20% FCSbefore adenovirus infection. After removal of the me-
dium, 109 pfu/ml AdE2F1 solutions were added to the as a positive control. For CDK4 and CDK2 kinase assays,
the lysates were prepared 8 and 12 hours after infection,culture dishes for one hour with shaking every 15 min-
utes, and the cells were then incubated in 0.25% FCS respectively. Immune complexes were recovered by cen-
trifugation after incubating the cell lysates for two hoursmedium for the indicated times. The samples were
washed twice with PBS and resuspended in 70% ethanol at 48C with 10 ml of anti-cyclin D1 antibody or anti-cyclin
E antibody (Santa Cruz Biotechnology Inc.) and then onefor at least 12 hours at 48C, and then the fixed and
permeabilized cells were collected by centrifugation and hour with 30 ml of protein G-plus agarose (Oncogene
Science, Uniondale, NY, USA). Immunoprecipitatedwere washed with PBS. The cells were denatured by
RNase, stained with propidium iodide, and analyzed by proteins were suspended in 30 ml of kinase buffer [50 mm
HEPES (pH 7.5), 10 mm MgCl2, 1 mm DTT] containingflow cytometry using a FACS Calibur (Becton Dickin-
son, San Jose, CA, USA). The percentages of the cells substrate [0.2 mg of soluble glutathione S-transferase-
pRb fusion protein (Santa Cruz Biotechnology Inc.) forin G1, S, and G2/M phases were then determined.
CDK4 kinase assay, and Histione H1 (Boeringer Mann-
Measurement of caspase 3 activities heim, Germany) for CDK2 assay] and 2.5 mm EGTA,
10 mm b-glycerophosphate, 1 mm NaF, 20 mm ATP, andA Caspase 3 Fluorometric Protease Assay Kit (MBL,
10 mCi of [g-32P] ATP (NEN, DuPont, Boston, MA,Tokyo, Japan) was used for measurement of caspase 3
USA). After incubation for 30 minutes at 308C withactivities. In brief, cells were plated in six-well dishes,
occasional mixing, the samples were boiled in polyacryl-cultured in starved medium for 48 hours, transfected by
amide gel sample buffer containing sodium dodecyl sul-adenovirus, and incubated in starved medium that was
fate and separated by electrophoresis. Phosphorylatedchanged once daily. At indicated times, the cells were
proteins were analyzed by BAS station.collected and lyzed in lysis buffer, and the protein con-
centration was normalized by the Bradford assay. The
Statistical analysislysates were incubated with the same amount of reaction
buffer and 50 mm DEVD-AFC substrate for two hours The results were given as means 6 sem. The signifi-
cance of difference was tested using analysis of varianceat 378C. Fluorescence was monitored with an excitation
wavelength of 400 nm and an emission wavelength of in multiple comparisons. P , 0.05 was considered statisti-
cally significant.505 nm.
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Fig. 1. (A) Increase of the number of mesangial cells after fetal calf serum (FCS) stimulation. The mesangial cells were incubated in starved
medium for 48 hours and were then stimulated by replacement with 20% serum-containing medium. After indicated times, the cells were incubated
with WST-8 for two hours. Absorbance that reflected the number of living cells was measured. Each point represents the mean 6 sem of four
experiments. *P , 0.05 vs. control; **P , 0.05 vs. 18 hours by analysis of variance (ANOVA) test. (B) Time course of [3H]-thymidine incorporation
after serum stimulation. The mesangial cells were treated as described in (A). After indicated times, the cells were incubated with [3H]-thymidine
for two hours. Each bar represents the mean 6 sem of four experiments. *P , 0.05 vs. control by ANOVA.
RESULTS of mesangial cells pass through the G1/S phase at some
point between 6 and 12 hours and then pass through theTime course of the mesangial cell cycle
G2/M phase at some point between 12 and 18 hours.
To characterize mesangial cell proliferation, we exam-
ined cell number and DNA synthesis after growth stimu- Expression of the E2F family in rat mesangial cells
lation. Mesangial cells were made quiescent by incuba- To determine which member of the E2F family is
tion in starved medium for 48 hours and then stimulated important and involved in mesangial cell proliferation,
by replacement in medium containing 20% FCS. After the time course of protein expression of the E2F family
the indicated times, the cells were incubated with WST-8 after FCS stimulation was examined, and it was com-
for two hours, and then the absorbance that reflects the pared with the mesangial cell cycle discussed earlier in
surviving cell number was measured. Figure 1A shows this article. Mesangial cells were rendered quiescent and
that the number of mesangial cells increased by about stimulated by FCS using the same methods described in
twofold at 18 hours. This data indicated that the M phase Figure 1. Nuclear protein was extracted at indicated
started between 12 and 18 hours after FCS stimulation times. As shown in Figure 2A, protein expression of
in our condition. We examined [3H]-thymidine incorpo- E2F1 through E2F3 was induced by FCS stimulation.
ration after FCS stimulation (Fig. 1B). The mesangial The expression of E2F1 was almost undetectable in a
cells were treated as described earlier in this article and quiescent state and was only slightly detectable at six
then incubated with [3H]-thymidine for two hours. [3H]- hours after FCS stimulation. It strongly increased from
thymidine incorporation was significantly increased 6 12 hours after FCS stimulation. This time course was
hours after FCS stimulation and reached at its peak after consistent with the result of [3H]-thymidine incorpora-
12 hours. These data suggested that almost all of the tion. Although protein expression of E2F2 and E2F3
mesangial cells entered the S phase at some point be- resembled that of E2F1, magnitudes of their changes
tween 6 and 12 hours and exited the S phase at some were notably smaller than that of E2F1 expression. The
increases of E2F2 and E2F3 were obscure comparedpoint between 12 and 18 hours. To be brief, the majority
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Fig. 3. Time course of E2F1 overexpression after AdE2F1 infection.
The mesangial cells were incubated in starved medium for 48 hours
and infected with 109 pfu/ml AdE2F1. Nuclear protein was extracted
after indicated times. Western blotting was performed with same
amount of nuclear protein.
not be distinguished. We focused on E2F1 in the follow-
ing study because the E2F1 expression exceeded E2F2
and E2F3 expression during cell cycle progression in
mesangial cells.
The time course of the expression of E2F1 mRNA
was also examined. Figure 2B shows that E2F1 mRNA
increased moderately at three hours after FCS stimula-
tion and increased strongly at 12 hours. The time course
Fig. 2. (A) Induction of E2F family (E2F1 through E2F4) protein of mRNA expression was almost the same as that of
expression after serum stimulation in rat mesangial cells. Western blot protein expression. The similarity between these timeanalysis was performed with a specific antibody for E2F family individu-
courses suggested that the transcriptional regulation ofals. Primary cultured rat mesangial cells were incubated in starved
medium for 48 hours to render them quiescent. Nuclear protein was E2F1 is important in the mesangial cell cycle.
extracted at indicated times after stimulation with 20% FCS. Aliquots
of the nuclear protein were electrophoresed on a SDS-polyacrylamide Regulation of cell cycle by E2F1 overexpression in ratgel and visualized by the ECL chemiluminescence system. (B) Induction
mesangial cellsof E2F1 mRNA expression after stimulation in rat mesangial cells. The
mesangial cells were incubated in starved medium for 48 hours to render
Adenovirus-mediated gene transfer was used to inves-them quiescent. Total RNA was extracted at indicated times after
stimulation with 20% FCS extracted as described in the Methods sec- tigate whether the overexpression of E2F1 could pro-
tion. Aliquots of total RNA (20 mg per lane) were electrophoresed on mote cell cycle progression. In our previous study, we
a 1% agarose gel. The membrane was hybridized sequentially using a
demonstrated the efficiency of transfection and the toxic-specific cDNA probe for E2F1. Ribosomal RNA (18S) is shown as a
control for RNA loading. ity by means of adenovirus-mediated transfection to mes-
angial cells [6]. At first the time course of E2F1 protein
expression was examined after AdE2F1 infection. The
quiescent mesangial cells were infected with 109 pfu/mlwith the increase of E2F1 in the G1/S phase transition.
AdE2F1. Then the mesangial cells were harvested atIn contrast, protein expression of E2F4 was highest
indicated times and the nuclear protein extracted. Figureamong the E2F family in the quiescent state, but it
3 shows that E2F1 expression significantly increased 6showed only a slight increase during FCS stimulation.
hours after infection and continued thereafter up to atThe expression of E2F4 increased at six hours. E2F4
least 30 hours.appeared to be mainly expressed in cytosols without
We investigated whether only E2F1 overexpressiongrowth simulation [33, 34]. When we extracted nuclear
could promote DNA synthesis and cell cycle progression.protein to detect slight changes after growth stimulation,
The quiescent mesangial cells were infected by variousit was expected that E2F4 expression at zero hours, in-
concentrations of AdE2F1 for 24 hours, and then thecluding cytosolic fraction, would exceed the expression
[3H]-thymidine incorporation was measured. As shownwe detected here. Some studies showed E2F4 did not
in Figure 4, overexpression of E2F1 in rat mesangial cellschange the amount of expression through the cell cycle
increased thymidine uptake to 220% in the absence ofand had no influence in promoting the cell cycle [35].
FCS stimulation, which is an almost equal level to thatThese data suggest that the E2F1, E2F2, and E2F3 corre-
induced by 20% FCS stimulation.late with mesangial cell proliferation. The peak of ex-
Next, the mesangial cell cycle progression was exam-pression of E2F3 at 18 hours was late for a peak in DNA
ined using flow cytometry. Mesangial cells were infectedsynthesis. In fact, which protein, E2F1 or E2F2, plays a
more important role in the mesangial cell cycle could with 109 pfu/ml AdE2F1, after indicated times harvested,
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Fig. 4. Effect of E2F1 overexpression on mesangial cell proliferation
as assessed by [3H]-thymidine incorporation. Quiescent mesangial cells
cultured in starved medium for 48 hours were incubated with indicated Fig. 5. Cell cycle analysis using flow cytometry after E2F1 overexpres-
dosages of AdE2F1. Control mesangial cells were infected with 109 pfu/ml sion. Mesangial cells were brought to quiescence as described in Figure
AdLacZ. Twenty-four hours after incubation, they were pulsed with [3H]- 3, were infected with 109 pfu/ml AdE2F1, and subsequently collected
thymidine for four hours. Each bar represents the mean 6 sem of four at indicated times. The cells were stained with propidium iodine and
experiments. *P , 0.05 vs. control by analysis of variance test. processed for flow cytometry. (A) Representative tracing. The hori-
zontal axis reflects relative DNA content and the vertical axis represents
cell number. (B) The percentage of gated control and AdE2F1-infected
cells in each phase of the cell cycle was graphed from the flow cytometric
analysis. Each bar represents the mean 6 sem of four experiments.and were investigated to determine the amount of DNA
*P , 0.05 vs. 0 hours by ANOVA.content. Figure 5A illustrates an experimental plotting
of the cell number as a function of DNA content at 0,
12, and 24 hours. The data, summarized in Figure 5B,
revealed that overexpression of E2F1 alone significantly [36–39]. We observed the cell viability over a long time
increased the percentage of the S phase and decreased course after the overexpression of E2F1. Mesangial cells
the percentage of the G0/G1 phase. The percentage of were cultured in starved medium to maintain quiescence
the G2/M phase was increased by E2F1 overexpression, for two days. Next, we transfected cells with 109 pfu/ml
although it is not statistically significant. These data sug- AdE2F1 or with the same amount of AxCALacZ as a
gest that mesangial cells progress from the G1 phase to control. After the indicated times, we incubated the cells
the S phase at same point from six hours after E2F1
with WST-8 for two hours and then measured the ab-overexpression and then onward to the M phase at same
sorbance that reflects the surviving cell number. Figurepoint from 18 hours.
6A showed a twofold increase in the number of livingWe concluded that overexpression of E2F1 alone
mesangial cells 24 hours after E2F1 overexpression.could accelerate the G1/S phase transition and promote
Thereafter, the number of living mesangial cells quicklymesangial cell proliferation. In other words, E2F1 up-
decreased from 48 hours, whereas the number of controlregulation is sufficient for rat mesangial cell proliferation
cells gradually increased up to 72 hours.in certain conditions.
Caspase 3 protease activity was measured to determine
Induction of apoptosis by E2F1 overexpression in rat whether this decrease from 48 hours reflected apoptosis.
mesangial cells The mesangial cells were treated in the same manner de-
scribed in Figure 6A. After the indicated times, cell lysatesSome studies reported that overexpression of E2F1
induced apoptosis after the induction of the S phase were prepared and normalized by protein concentration.
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Figure 6A. These data suggested that E2F1 overexpres-
sion completed the mesangial cell cycle and doubled the
number of living cells. After that, E2F1 overexpression
induced apoptosis.
Induction of the G1 cyclins, cyclin D1, cyclin E, and
cyclin A by E2F1 overexpression
To elucidate the mechanisms of E2F1-induced mesan-
gial cell cycle progression, we investigated the interaction
between E2F1 and G1 cyclins. We previously reported
that G1 cyclins play an important role in the mesangial
cell cycle [6, 9]. These G1 cyclins are well known to have
E2F binding sites in their promoter region [22, 24–26].
However, the network of G1 cyclins and E2F1 has not
been clear, and the interaction between G1 cyclins and
E2F has not been investigated in primary cultured mes-
angial cells. To clear the regulation of G1 cyclins and
E2F1 in detail, we studied the promoter activity and pro-
tein expression of G1 cyclins after E2F1 overexpression.
We transfected plasmids containing the cyclin D1,
cyclin E, or cyclin A promoter region with luciferase
reporter gene to rat mesangial cells by electroporation
methods, and then E2F1 was overexpressed using adeno-
virus vector. Figure 7A showed that E2F1 overexpres-
sion significantly increased cyclin D1, cyclin E, and cyclin
A promoter activity 5.7-fold, 30.8-fold, and 12.8-fold,
respectively.
Figure 7B showed the time course of G1 cyclin protein
expressions after AdE2F1 infection. The quiescent mes-
angial cells were infected with AdE2F1 in starved me-
dium. Surprisingly, overexpression of E2F1 caused a se-
quential induction of three G1 cyclins identical to a
sequential induction triggered by growth stimulation.
E2F1 increased cyclin D1 from 6 hours up to a peak at
12 hours, and it increased cyclin E and cyclin A from 12
and 18 hours, respectively. We also performed quantita-Fig. 6. (A) Change the number of living mesangial cells after E2F1
overexpression. The mesangial cells were incubated for 48 hours in tive analysis of protein expressions of G1 cyclins (Fig.
starved medium. After that, the cells were infected with 109 pfu/ml 7C). This result was consistent with the time course of
AdE2F1 (———) or AxCALacZ (- - - - -) as a control. The starved
flow cytometry analysis. The mesangial cells entered themedium was changed every day. After the indicated times, the cells
were incubated with WST-8 for two hours. The absorbance that reflects S phase from 6 hours after E2F1 overexpression and
the number of surviving cells was measured. Each point represents the exited the S phase from 18 hours.
mean 6 sem of three experiments. (B) Induction of caspase 3-like
We examined whether this induction of G1 cyclinsprotease activity by E2F1 overexpression. The mesangial cells were
treated as described in (A) and were infected with 109 pfu/ml AdE2F1 contributed to the increased kinase activities of CDK4
(j) or AxCALacZ ( ) as a control. After indicated times, cell lysates and CDK2, respectively. Eight hours of AdE2F1 infec-
were prepared and normalized by protein concentration. Caspase 3-like
tion increased CDK4 kinase activity to a level almostprotease activity was measured by proteolytic cleavage of the specific
fluorogenic substrate DEVD-AFC. Each bar represents the mean 6 equal to that induced by eight hours of FCS stimulation.
sem of three experiments. (Fig. 8, upper panel). CDK2 activity was also increased
2.8 times by E2F1 overexpression for 12 hours (Fig. 8,
lower panel), but it was only minimally increased by
E2F1 overexpression for eight hours (data not shown).Caspase 3-like protease activity was measured by proteo-
lytic cleavage of the specific fluorogenic substrate These data suggest that E2F1 initiates G1/S phase
transition not only by induction of genes required forDEVD-AFC. Caspase 3-like protease activity was sig-
nificantly increased at 48 and 72 hours compared with DNA synthesis, but also by induction G1 cyclins. E2F1
and G1 cyclins strongly cooperate in promoting the G1/Scontrol, but it was lower than control at 24 hours. This
increase was consistent with the time course showed in phase transition in mesangial cells.
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Fig. 7. (A) Effects of E2F1 overexpression on the transcriptional activ-
ity of the cyclin D1, cyclin E, and cyclin A promoters. Mesangial cells
were equilibrated to the cell cycle phase and subsequently grown in
serum containing medium as described in the Methods section. The
cells were transfected with cyclin D1, cyclin E, or cyclin A promoter
plasmids containing luciferase reporter gene by the electroporation
method. After an additional 24 hours of growth, the cells were infected
with indicated dosages AdE2F1 or AxCALacZ (control). The cells were
collected and assayed for luciferase activities. The results represent the
means 6 sem of relative luciferase activities (after collection by protein
concentration) from four experiments. (B and C) Effect of E2F1 overex-
pression on the induction of the cyclin D1 (r), cyclin E (j), and cyclin
A (m) proteins. Mesangial cells were brought to quiescence by 48-
hour serum withdrawal and infected with 109 pfu/ml AdE2F1. Nuclear
proteins were extracted indicated times after infection. Aliquots of the
nuclear protein were separated on a SDS-PAGE and visualized by the
ECL chemiluminescence system (B). Quantitative analysis of protein
expressions of G1 cyclins was performed using DNAquant (C).
DISCUSSION the peak in E2F3 expression was late for S phase, and
E2F1 and E2F2 expressions increased over a time courseIn this study, we demonstrated for the first time that
consistent with that of G1/S phase transition. E2F1 ex-E2F expression was a necessary and sufficient condition
pression increased 20-fold from 6 to 12 hours, whereasfor mesangial cell proliferation. Moreover, the same case
E2F2 expression increased by no more than twofold. Wemay hold true in many other cell lines as well. The p16/
presumed that E2F1 was a major protein among the E2FRb/E2F regulatory pathway is one of the most frequent
family in mesangial cell cycle progression.targets of genetic alterations in human cancers [40]. This
E2F1 overexpression increased [3H]-thymidine incor-suggests that the regulation of this pathway differs in
poration and the percentage of cells in the S phase. Incarcinoma cells and primary culture cells. Several recent
our flow cytometry study, E2F1 overexpression tended tostudies showed that E2F and G1 cyclins were effective
increase the percentage of cells in the G2/M and G0/G1therapeutic targets of mesangial proliferative disease [20,
phases at 24 hours, with a twofold increase in the number21, 41]. We therefore thought it was important to clarify
of living cells at that time point. The percentage of cellsthe regulation of mesangial cell cycle by E2F for future
that progressed to S and G2/M phases was smaller thantherapeutic use.
the percentages previously reported in other cell lines.We showed that E2F1, E2F2, and E2F3 expressions
We recognize that this discrepancy may be due to thewere increased by serum stimulation, whereas E2F4 ex-
tendency of mesangial cells to stay quiescent, the highpression was not (Fig. 2A). E2F1, E2F2, and E2F3 are
expression of cyclin-dependent kinase inhibitor [28], orwell known to be distinctly different from E2F4. Namely,
the efficiency of the gene transfer to the primary culturethe former stimulate cell cycle progression, whereas the
cell in our system. In any case, these data suggested thatlatter does not [42]. However, there are no clear differ-
E2F1 overexpression could induce the G1/S phase transi-ences between E2F1, E2F2, and E2F3 in terms of their
ability to induce cell cycle progression. In mesangial cells, tion and complete mitosis. Mesangial cells have been
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increase the protein level of cyclin D1. Watanabe et al
reported that E2F1 overexpression decreased cyclin D1
expression dependent on the Sp1 binding site [51]. Fur-
thermore, Ohtani, Degregori, and Nevins showed that
E2F1 overexpression activated cyclin D1 promoter with-
out increasing the protein level [24]. Fan and Bertino
suggested that there may be a positive feedback regula-
tion loop between E2F and cyclin D1 by means of a
dominant negative mutant of E2F1 [52]. In our data,
E2F1 overexpression increased both the promoter activ-
ity and protein expression of cyclin D1. Our study is the
first to report an interaction between E2F and G1 cyclins
in primary cultured cells, and we postulate that the differ-
Fig. 8. Induction of CDK4 and CDK2 kinase activity by E2F1 overex- ence in cyclin D1 regulation induced by E2F1 reflects a
pression. The mesangial cells were incubated with starved medium for difference in the mechanisms that regulate G1/S phase48 hours and then either infected with 109 pfu/ml AdE2F1 or stimulated
transition between primary cultured cells and immortalby FCS as a positive control. After 8 hours for the CDK4 kinase assay
and 12 hours for the CDK2 kinase assay, cell lysates were immunopre- cells. In our preliminary experiments, E2F1 overexpres-
cipitated with anti-cyclin D1 antibody and anti-cyclin E antibody, re- sion increased cyclin D1 promoter activity but not pro-spectively. Kinase assays were performed with Rb protein or Histone
tein expression in LLC-PK1 cells (data not shown).H1 as a substrate for CDK4 and CDK2, respectively.
Cyclin D1/CDK4 and cyclin E/CDK2 complexes facili-
tate phosphorylation of the pRb family with the release
of free E2F, and then the released E2F increases G1
rarely investigated to determine whether the introduc- cyclins and promotes G1/S phase progression. E2F and
tion of an exogenous gene facilitates the cell cycle. To G1 cyclins form the firm, positive feedback loop. Late
our knowledge, this is the first report in which the expres- induction of cyclin A may contribute to the reduction
sion of a single gene promotes cell cycle re-entry and of DNA-binding activities of the E2F1-DP-1 dimer
completes mitosis in mesangial cells. [53–55], in other words, form negative feedback loop.
It is well known that E2F1 overexpression causes apo- Various studies have demonstrated that the expres-
ptosis [36–39]. The mechanisms of E2F1-induced apo- sions of specific cyclins and CDKs and CDK inhibitors
ptosis have been reported to act in both p53-dependent change during mesangial cell proliferation in cell culture
and p53-independent manners. Although it remains un- systems [5–9] and in in vivo experimental models [10].
clear precisely how E2F1 induces apoptosis, the process Some studies indicated that inhibition of CDKs or E2F
is not simply an artifact of protein overexpression. The suppressed mesangial cell proliferation [20, 21, 41].
induction of apoptosis is specific to E2F1 among the E2F Smooth muscle cell proliferation after endothelium in-
family, and neither E2F2 nor E2F3 have been showed jury was suppressed by infusion of an E2F decoy oligonu-
to have any connection with apoptosis [43]. In mesangial cleotide [56]. These experiments suggest new therapeutic
cells, E2F1 overexpression induced apoptosis at 48 hours approaches to benign proliferative disease. Because most
after infection. At this time point, mitosis was completed of our knowledge about cell cycle regulation is based on
once. Caspase 3 activity was also increased at 48 hours. experiments using cells derived from carcinoma, it is
We speculate that E2F1 overexpression induces proper important to clarify the difference in the cell cycle regula-
cell division, whereas continuous E2F1 expression or tion between primary culture cells and cell lines.
E2F1-induced gene expression at an inappropriate phase Studies of cell cycle regulatory proteins, including
causes apoptosis. Some studies reported that apoptosis cyclins and E2F in human renal disease, have not yet
was increased in the progression of glomerular sclerosis. been reported. Mesangial cell proliferation continues for
Further studies are needed to elucidate the relationship a few decades in human chronic glomerulonephritis, and
between progression of glomerular sclerosis and E2F1- it is not clear whether cell cycle regulatory genes such
induced apoptosis. as cyclins and E2F are involved in the pathogenesis of
Various experiments suggest that free E2F increases this disease. Further studies are needed to determine
the expression of genes required for DNA synthesis, as whether these cell cycle control mechanisms are involved
well as regulatory genes such as c-myc, N-myc, erb-B, in such a long-term proliferation.
c-myb, and B-myb [44–50]. It is also well known that
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